"The strong global launch of YORVIPATH positions 2025 to be an inflection point for Ascendis with growing revenue and a path to cashflow breakeven in the near term,” said Jan Mikkelsen, Ascendis ...

Copenhagen, Denmark, May 1, 2025 - Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based ...

Square Pharma posted a profit of Tk 605 crore in the third quarter of the 2024-25 fiscal year, up 18 percent year-on-year, according to its financial statements. For all latest news, follow The ...

Silo Pharma’s SP-26 met all preclinical endpoints and aims to qualify for the FDA’s streamlined 505(b)(2) pathway. Today's manic market swings are creating the perfect setup for Matt’s next ...

From innovative treatments to unequal access to medicine, I cover health topics and keep an eye on Switzerland's Health Valley. I'm Swiss-Turkish, and have a background in communications ...

Following a long and turbulent search for a fresh set of decision makers, Jacksonville Jaguars owner Shad Khan introduced his team’s new general manager in February as someone who had “already ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Dasatinib Tablets in different ...

Big Pharma isn’t sure how to handle Donald Trump’s Republican Party. Trump is pledging to impose tariffs on drug imports, while Health Secretary Robert F. Kennedy Jr. has vilified the drug ...

Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the sector, which pharma giant Pfizer privately warned could damage the Irish ...

PHILADELPHIA, April 24, 2025--(BUSINESS WIRE)--PCI Pharma Services ("PCI") – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies ...

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in ...

PHILADELPHIA — PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake ...